EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents
infringement in Pharmaceuticals
MIAMI, December 28, 2012
MIAMI, December 28, 2012 /PRNewswire/ --
EmergingGrowth.com, a leading digital financial media company, Reports on
RVPlus, Inc., Oil and Gas and Patents infringement in Pharmaceuticals.
Feature your company on EmergingGrowth.com. Visit EmergingGrowth.com to find
RV Plus (OTCBB: RVPL) just announced that it has generated a total amount of
$14,610,576 in accounts receivable as of today for 2012 year from long-term
contracts with foreign governments to supply goods and services that support
carbon-emissions reduction, energy efficiency, in addition to supporting
climate change, environment, forestry, social affairs, and agriculture.
In the past six months, the company has made entry into three definitive
material agreements with foreign government parties for goods and services,
holding a total value of $1,900,500,000 (USD), which are associated to Civil
Society Programs, collectively organized by United Nations affiliates and
Parties in Latin America, West Indies, and Africa.
Cary Lee Peterson has told press that he will be publishing a year-end letter
to shareholders on January 1, 2013 to recap on 2012 year for the Company and
provide details of plans for ECCO2 Tech and partners in 2013. If RVPL can
materialize these contracts in the near term, we could see a dramatic move in
the company's valuation and share price. Please visit the Company's website
for a deeper understanding on the process.
Tamm Oil and Gas Corporation (OTCBB: TAMO) recently entered into an agreement
with private company CEC North Star Energy Ltd to do work pertaining to their
recently purchased additional third party trade seismic which after
reprocessing and analysis continues to support the existence of the Bluesky
channel of the Norh Star Lands. Based on this seismic, 4 well locations were
surveyed recently and the licensing process will be initiated in the next few
weeks with an expected completion prior to break up.
Globalstar, Inc. (OTCBB: GSAT) recently announced that it received a delisting
notice from NASDAQ do to the fact that it's share price has fallen below $1.00
per share in excess of the time period permitted by NASDAQ rules. The company
after a recent appeal to NASDAQ requested a further extension and was denied.
The six time patent infringement in pharmaceuticals case plaintiff Depomed
(NASDAQ: DEPO) is making progress in battles. Watson Pharmaceuticals (NYSE:
WPI) withdrew its application for the competing drug generic Gralise, and the
suit against Impax Laboratories (NASDAQ: IPXL) was dismissed after the
withdrawal of their application. The road is getting clearer as the
competition is fading. Look for Depomed to react.
By offering 100% original and unmatched content by the best financial
reporters, writers and bloggers in the business, EmergingGrowth.com is
emerging as a leading digital financial media portal. Its services provide
users, subscribers and advertisers with a variety of content and tools through
a range of online, social media, mobile and other mobile outlets.
Since its inception, EmergingGrowth.com has distinguished itself from other
financial media companies with its sly approach to reading between the lines
in order to locate that needle in the haystack. Sign up today to see what
EmergingGrowth.com has to offer.
NEW: Feature your company on EmergingGrowth.com. Find out how by filling out
our form at
Join our Linked in Group
Like us on Facebook
All information contained herein as well as on the EmergingGrowth.com website
is obtained from sources believed to be reliable but not guaranteed to be
accurate or all-inclusive. All material is for informational purposes only, is
only the opinion of EmergingGrowth.com and should not be construed as an offer
or solicitation to buy or sell securities. From time to time,
EmergingGrowth.com receives compensation by the companies profiled in its
emails, press releases or on its website. If any compensation is received it
appears fully detailed in a " special disclosure " on our website as well as
on any pages or emails where that company is located. Please check the "
Special Disclosure " link ( http://www.emerginggrowth.com/special-disclosure )
and consult an investment professional before investing in anything viewed
within. In addition, Please make sure you read and understand the Terms of
website. Always remember that investing in securities such as the ones listed
within are for high-risk tolerant individuals only and not the general public.
Whether you are an experienced investor or not, you should always consult with
a stockbroker, financial advisor, or similar before purchasing or selling any
securities viewed on any emails sent from EmergingGrowth.com or its website.
Contact: Contact: EmergingGrowth.com, info@EmergingGrowth.com, +1-305-323-5687
Press spacebar to pause and continue. Press esc to stop.